Cannabis Use Disorder and Bipolar II Disorder Share a Familial Risk Factor

A JAMA Psychiatry study of 1,284 people and their relatives found that bipolar II disorder and cannabis use disorder cluster in the same families, suggesting a shared underlying vulnerability, with mood episodes typically starting before cannabis problems.

Quick, Courtney R et al.·JAMA psychiatry·2022·Strong EvidenceCross-Sectional
RTHC-04156Cross SectionalStrong Evidence2022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Strong Evidence
Sample
Not reported

What This Study Found

CUD in probands was associated with increased CUD in relatives (aOR 2.64). Bipolar II (but not bipolar I or major depression) was also associated with CUD in relatives (aOR 2.57). Among relatives, CUD was associated with bipolar II (aOR 4.50) and major depression (aOR 3.64). Mood episodes typically preceded CUD onset.

Key Numbers

CUD in probands predicted CUD in relatives (aOR 2.64, 95% CI 1.20-5.79). BP-II predicted CUD in relatives (aOR 2.57, 95% CI 1.06-6.23). Rates of CUD were highest in relatives with both familial and individual BP-II history (28.6% vs 7.2% with neither). Mood episodes preceded CUD in most cases.

How They Did This

Community-based family study in the Washington, DC area (2004-2020). 586 adult probands and 698 first-degree relatives underwent semistructured diagnostic interviews. Mixed-effects models estimated familial aggregation of CUD with mood disorders, adjusting for demographics and comorbidities.

Why This Research Matters

The specific link with bipolar II (but not bipolar I) is new and clinically significant. If a shared genetic vulnerability underlies both conditions, then treating bipolar II early might actually help prevent cannabis use disorder.

The Bigger Picture

This adds genetic evidence to the long-debated question of whether cannabis causes mental illness or whether shared vulnerabilities drive both. The finding that mood episodes typically come first, combined with the family clustering, suggests a shared diathesis model where underlying vulnerability leads to both conditions.

What This Study Doesn't Tell Us

Cross-sectional design cannot definitively establish temporal ordering. The DC metro sample may not represent all populations. Lifetime diagnoses may be subject to recall bias. The relatively small number of CUD cases (55 probands, 68 relatives) limits statistical power for subgroup analyses.

Questions This Raises

  • ?Would early bipolar II treatment reduce CUD onset?
  • ?What specific genetic variants underlie the shared vulnerability?
  • ?Does this family clustering extend to cannabis use without meeting disorder criteria?

Trust & Context

Key Stat:
Bipolar II in probands predicted 2.6x increased CUD risk in relatives
Evidence Grade:
Strong: published in JAMA Psychiatry with structured diagnostic interviews, family design, and appropriate statistical controls.
Study Age:
Published in 2022, with recruitment from 2004-2020.
Original Title:
Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study.
Published In:
JAMA psychiatry, 79(7), 727-735 (2022)
Database ID:
RTHC-04156

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

Does bipolar disorder cause cannabis addiction?

The study found a shared familial risk, not direct causation. Bipolar II and CUD tend to run in the same families, suggesting a common underlying vulnerability. Mood episodes typically started before cannabis problems, which could mean people with bipolar II turn to cannabis to cope.

Why bipolar II but not bipolar I?

The study found the familial link was specific to bipolar II. The reason is unclear, but bipolar II is characterized by depression more than mania, and the shared vulnerability may relate more to depressive traits than manic ones.

Read More on RethinkTHC

Cite This Study

RTHC-04156·https://rethinkthc.com/research/RTHC-04156

APA

Quick, Courtney R; Conway, Kevin P; Swendsen, Joel; Stapp, Emma K; Cui, Lihong; Merikangas, Kathleen R. (2022). Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study.. JAMA psychiatry, 79(7), 727-735. https://doi.org/10.1001/jamapsychiatry.2022.1338

MLA

Quick, Courtney R, et al. "Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study.." JAMA psychiatry, 2022. https://doi.org/10.1001/jamapsychiatry.2022.1338

RethinkTHC

RethinkTHC Research Database. "Comorbidity and Coaggregation of Major Depressive Disorder a..." RTHC-04156. Retrieved from https://rethinkthc.com/research/quick-2022-comorbidity-and-coaggregation-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.